Biocure Technology (XCNQ:CURE) Current Accrued Expense : C$0.00 Mil (As of Jun. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Biocure Technology Current Accrued Expense?

Biocure Technology's Current Accrued Expense for the quarter that ended in Jun. 2024 was C$0.00 Mil.

Biocure Technology's annual Current Accrued Expense declined from Dec. 2021 (C$0.09 Mil) to Dec. 2022 (C$0.00 Mil) but then stayed the same from Dec. 2022 (C$0.00 Mil) to Dec. 2023 (C$0.00 Mil).

Biocure Technology Current Accrued Expense Historical Data

The historical data trend for Biocure Technology's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocure Technology Current Accrued Expense Chart

Biocure Technology Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

0.06

0.20

0.09

Biocure Technology Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Current Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Biocure Technology Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Biocure Technology Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Biocure Technology's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Biocure Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocure Technology Inc (XCNQ:CURE) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

1WH0:Germany

Address

1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 2E9

Website

https://www.biocuretech.com

Biocure Technology Inc is a South Korean-based Bio-Pharmaceutical company specializing in the development and potential commercialization of biosimilar pharmaceutical products. It Developing Biosimilars and CAR-T Cell pharmaceuticals. Its products are CAR-T Cell Therapy, Interferon Beta, Ranibizumab, and PEG-Filgrastim.

Executives

Konstantin Lichtenwald

Director, Senior Officer